Integra Biosciences Corp.

Integra Biosciences Corp., a foreign-owned manufacturer headquartered in Hudson, New Hampshire, sells advanced laboratory equipment and services to federal agencies as a prime contractor (100% of recent awards), competing predominantly under full-and-open procurement vehicles with occasional small-business set-asides. The company specializes in liquid handling systems, automated pipetting platforms, media preparation equipment, and calibration and preventive maintenance services for those instruments across civilian research and diagnostic agencies.

Integra's federal footprint is concentrated in health and life sciences research. The top five customer agencies by award count account for 52% of recent awards and center on the National Institutes of Health ecosystem: NIH Office of the Director (55 awards, $309 thousand combined potential value), the National Institute of Allergy and Infectious Diseases (39 awards, $1 million), the Centers for Disease Control and Prevention Pittsburgh (36 awards, $933 thousand), the Food and Drug Administration (32 awards, $898 thousand), and the National Institute of Environmental Health Sciences (18 awards, $415 thousand). When ranked by potential value, NIAID, CDC, and FDA hold the largest dollar exposure. Integra's capability portfolio centers on equipment sales and service agreements. Representative examples include a $67,152 delivery order from the National Center for Advancing Translational Sciences in August 2026 for WellJet dispenser equipment with installation and training; a $82,936 purchase order from the Defense Health Agency in September 2023 for WellJet dispensers, accessories, and preventive maintenance; and a $162,099 purchase order from the Fish and Wildlife Service in July 2024 for VIAFLO pipetting systems and services. The source notes that Integra has secured over 80 prime federal contract awards totaling approximately $1.3 million since 2021.

Activity has contracted materially. Integra recorded 29 awards in 2022, declining to 11 in 2024 and 6 in 2025, with 7 awards in 2026 year-to-date. The combined potential value across all 344 awards in the portfolio is $38.4 million, with obligated dollars at $7.5 million (19% of potential value), indicating most contracts remain unfilled or low-velocity. Six awards (combined potential value $207 thousand) face ultimate completion within the next twenty-four months and expose Integra to recompete risk on that dollar magnitude. The vendor operates primarily under the General Services Administration's Multiple Award Schedule, where 77 task orders carry $2.2 million in combined potential value. Award concentration by NAICS is pronounced: 226 awards fall under Analytical Laboratory Instrument Manufacturing (NAICS 334516), with the remainder scattered across merchant wholesale and medical equipment categories. The top PSC is Laboratory Equipment and Supplies (290 awards), followed by maintenance and repair service codes.

Integra competes full-and-open but accepts Total Small Business set-asides when offered; approximately eight awards in the recent portfolio carry that designation. The vendor has one recorded sub-award — a November 2024 modification for WellJet dispenser stacker purchase, with no prime identified in the source. The company's business model is transactional and equipment-centric, with small-dollar purchase orders and delivery orders dominating the award structure rather than long-term service contracts. Federal customer relationships span two decades (earliest award in the source data is January 2008), but velocity and dollar concentration suggest a mature, low-growth position in a fragmented procurement landscape dominated by equipment consumables and spot maintenance buys.

Provider of high-quality laboratory tools for liquid handling, media preparation, sterilization and cell cultivation.